News

Partnership spins new chapter for ‘spider silk’ proteins

22/01/2024

Germany-based synthetic silk developer AMSilk has teamed up with Swedish bioproduction group 21st.BIO to ramp up its “spider silk”-like protein production.  21st.BIO's scientists have developed new production strains, fermentation and processes to boost production and significantly reduce unit costs.  This will enable AMSilk to further broaden...

To continue reading this story, please sign in or register.

Related stories:

AMSilk secures €52 million to boost scale-up 09/09/2025
AMSilk heads to France 23/10/2024
Biotech silk readies for commercialisation 21/06/2024
The ‘untapped potential’ of natural and biotech fibres 19/06/2024
Proteins and biobased polymers provide performance for jacket 19/06/2024
AMSilk fundraising will help meet market demand for biopolymers 11/04/2023
AMSilk tailoring proteins for performance textiles 16/02/2023
Move to new HQ will support expansion, AMSilk says 02/11/2022
Biomaterials demand far exceeds supply - report 10/12/2020
AMSilk creates chief operating officer role for greater push towards brands 06/10/2020
AMSilk wants to fly higher 12/09/2018
AMSilk CEO to speak at San Francisco event 29/09/2017
AMSilk recognised as leader in innovation 25/08/2017
New certification will help AMSilk set up medical business unit 21/06/2017
Seasoned supply chain professional joins AMSilk 19/05/2017
AMSilk recruits ex-adidas and WL Gore product manager 05/05/2017
AMSilk cements its partnership with yarn manufacturer 28/04/2017

Sportstextiles.com cannot be held responsible for content if the language setting is changed from English.

The translations provided by Google Translate are automated and therefore might not be accurate and may contain incorrect, offensive or misleading language. We offer this facility as a guide only.